由右肺动脉封闭引起的肺高血压:Bmpr2突变的血液动力学后果
Alban Todesco1,2, Julien Grynblat2,3,4, Kouamé Kan Firmin Akoumia2
1Department of Thoracic Surgery, Diseases of the Esophagus and Lung Transplantation, North Hospital Aix Marseille University, Assistance Publique-Hôpitaux de Marseille Marseille France.
Journal of the American Heart Association
|July 9, 2024
概括
在Bmpr2突变的老鼠中,右肺动脉封闭引发肺高血压. 这种模型揭示了肺高血压发展和适应的性别和基因相关差异.
科学领域:
- 心血管研究研究心血管研究
- 肺高血压的病理生理学
- 心血管疾病的遗传学
背景情况:
- 遗传性肺动脉高血压与BMPR2基因突变有关,但不完全的透性表明其他因素也参与其中.
- 肺动脉狭窄可以导致内皮功能障碍和血管重塑,导致肺动脉压力升高.
- 这项研究调查了右肺动脉封闭 (RPAO) 是否可以在Bmpr2突变的老鼠中引发肺高血压 (PH).
研究的目的:
- 为研究肺高血压 (PH) 建立一种新的双击老鼠模型.
- 调查Bmpr2突变和性别在RPAO诱导的PH的发展和严重性的作用.
- 在这个模型中探索肺血管和心脏适应PH的情况.
主要方法:
- 具有Bmpr2突变的雄性和雌性大鼠和野生类型的兄弟姐妹经历了急性和慢性右肺动脉封闭 (RPAO).
- 进行了高准确度的血液动力学表征,以评估肺动脉压力和心脏功能.
- 肺部基因表达模式,包括IL-6和Gdf2,在慢性RPAO后在不受阻碍的领土上进行了分析.
主要成果:
- 在雄性和雌性大鼠中,RPAO诱导了毛囊前肺高血压 (PH),Bmpr2突变和雄性大鼠显示出更严重的PH.
- 与野生型大鼠相比,Bmpr2突变大鼠的死亡率更高,心脏收缩率明显下降.
- 慢性RPAO导致肺IL-6增加和Gdf2表达减少,在雄性大鼠中观察到更高的内甲素-1和IL-6水平.
结论:
- 开发的双击老鼠模型有效地模仿了肺高血压的关键方面.
- 该模型强调了对PH触发物的反应中与性别和基因相关的显著差异.
- 该模型为研究PH中右心室和肺血管适应提供了一个有价值的平台.
更多相关视频
相关概念视频
01:30Pulmonary Hypertension: Classification and Pathogenesis
167
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
167
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
152
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
152
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
156
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
156
01:17Measurement of Blood Pressure
907
Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a...
907